Prognostic value of cardiac troponin I in acute ischemic stroke patients treated with reperfusion therapy: a multicenter retrospective cohort study by Andrea Loggini (12077927)

Table_1_A Case–Control Study of ADCY9 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in the Chinese Han Population.DOCX by Xu Chao (303855)

“…In addition, haplotype analysis indicated that C_rs879620A_rs2230742A_rs2230741 haplotype was a protective factor for HCC (OR = 0.67, 95% CI = 0.50–0.89, p = 0.007, FDR-p = 0.028).…”

Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome by Larisa V. Lysenko (669533)

Serum calcium levels corrected for albumin. by Naoki Suzuki (308620)

“…Tenapanor significantly improved stool consistency and resolved constipation (BSFS types 1–2) by week 5. A transient increase in loose stools (BSFS types 6–7) occurred early, with 10 participants discontinuing due to diarrhea. …”

The proportion of the dosage of tenapanor. by Naoki Suzuki (308620)

“…Tenapanor significantly improved stool consistency and resolved constipation (BSFS types 1–2) by week 5. A transient increase in loose stools (BSFS types 6–7) occurred early, with 10 participants discontinuing due to diarrhea. …”

Table1_Impact of a tailored exercise regimen on physical capacity and plasma proteome profile in post-COVID-19 condition.docx by Mohammad Mobarak H. Chowdhury (19455133)

“…Individuals with no PCC served as a control group. The exercise program included cardiovascular and resistance exercises. …”

Supplementary Material for: Antagonistic Effects of Insulin and TGF-β3 during Chondrogenic Differentiation of Human BMSCs under a Minimal Amount of Factors by Hara E.S. (4149676)

Effects of ICI 182,780, an ERα and ERβ antagonist, and G-1, a GPER agonist, on autophagy in breast cancer cells by Mari Luminosa Muler (10473820)

Initial evaluation of an intervention to address provider implicit bias in pediatric sickle cell disease pain care: A mixed methods pilot study by Siddika S. Mulchan (21299553)

Table_1_Ataxia with oculomotor apraxia type 2 caused by a novel homozygous mutation in SETX gene, and literature review.DOCX by Shuaishuai Chen (7275431)

“…She had elevated AFP, increased serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) and decreased anti-Müllerian hormone (AMH) levels. We identified a novel homozygous missense mutation of the SETX gene, c.7118 C>T (p. …”

Table_1_Clinical Efficacy and Safety of Propranolol in the Prevention and Treatment of Retinopathy of Prematurity: A Meta-Analysis of Randomized Controlled Trials.DOCX by Haibo B. Kong (10122506)

“…</p><p>Results: Our original search identified 171 articles, and five studies met our criteria. A meta-analysis was performed that showed that infants orally treated with propranolol had a decreased risk of disease progression: stage progression had an RR = 0.65 [95% confidence interval (CI), 0.47–0.88]), plus disease had an RR = 0.43 [95% CI, 0.22–0.82]. …”

Serum Metabolomics of Incident Diabetes and Glycemic Changes in a Population With High Diabetes Burden: the Hispanic Community Health Study/Study of Latinos by Jin Choul Chai (11539355)

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes by Bruce A. Perkins (312635)

“…Consistent with the observed HbA1c decrease (8.0±0.9% to 7.6±0.9%, p<0.0001), normalized AUC_TOTAL CGM decreased from 153.7±25.4 to 149.0±30.2mg/dL∙h at end-of-treatment (p = 0.31), and significantly increased post-treatment (164.1±29.5mg/dL∙h, p = 0.02). …”

Table 7_Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology.xlsx by Printha Wijesinghe (14786473)

“…Introduction<p>Apolipoprotein E (ApoE) plays a crucial role in lipid homeostasis, predominantly expressed in astrocytes and to a lesser extent in microglia within the central nervous system (CNS). …”

Image 4_Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology.tif by Printha Wijesinghe (14786473)

“…Introduction<p>Apolipoprotein E (ApoE) plays a crucial role in lipid homeostasis, predominantly expressed in astrocytes and to a lesser extent in microglia within the central nervous system (CNS). …”

Table 6_Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology.xlsx by Printha Wijesinghe (14786473)

“…Introduction<p>Apolipoprotein E (ApoE) plays a crucial role in lipid homeostasis, predominantly expressed in astrocytes and to a lesser extent in microglia within the central nervous system (CNS). …”

Image 1_Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology.tif by Printha Wijesinghe (14786473)

“…Introduction<p>Apolipoprotein E (ApoE) plays a crucial role in lipid homeostasis, predominantly expressed in astrocytes and to a lesser extent in microglia within the central nervous system (CNS). …”

Image 7_Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology.tif by Printha Wijesinghe (14786473)

“…Introduction<p>Apolipoprotein E (ApoE) plays a crucial role in lipid homeostasis, predominantly expressed in astrocytes and to a lesser extent in microglia within the central nervous system (CNS). …”

Table 1_Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology.xlsx by Printha Wijesinghe (14786473)

“…Introduction<p>Apolipoprotein E (ApoE) plays a crucial role in lipid homeostasis, predominantly expressed in astrocytes and to a lesser extent in microglia within the central nervous system (CNS). …”

Image 6_Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology.tif by Printha Wijesinghe (14786473)

“…Introduction<p>Apolipoprotein E (ApoE) plays a crucial role in lipid homeostasis, predominantly expressed in astrocytes and to a lesser extent in microglia within the central nervous system (CNS). …”